Literature DB >> 1690424

Retroviral recombination during reverse transcription.

D W Goodrich1, P H Duesberg.   

Abstract

After mixed infection, up to half of related retroviruses are recombinants. During infection, retroviral RNA genomes are first converted to complementary DNA (cDNA) and then to double-stranded DNA. Thus recombination could occur during reverse transcription, by RNA template switching, or after reverse transcription, by breakage and reunion of DNA. It has not been possible to distinguish between these two potential mechanisms of recombination because both single-stranded cDNA and double-stranded proviral DNA exist in infected cells during the eclipse period. Therefore we have analyzed for recombinant molecules among cDNA products transcribed in vitro from RNA of disrupted virions. Since recombinants from allelic parents can only be distinguished from parental genomes by point mutations, we have examined the cDNAs from virions with distinct genetic structures for recombinant-specific size and sequence markers. The parents share a common internal allele that allows homology-directed recombination, but each contains specific flanking sequences. One parent is a synthetically altered Harvey murine sarcoma virus RNA that lacks a retroviral 3' terminus but carries a Moloney murine retrovirus-derived envelope gene (env) fragment 3' of its transforming ras gene. The other parent is intact Moloney virus. Using a Harvey-specific 5' primer and a Moloney-specific 3' primer, we have found recombinant cDNAs with the polymerase chain reaction, proving directly that retroviruses can recombine during reverse transcription unassisted by cellular enzymes, probably by template switching during cDNA synthesis. The recombinants that were obtained in vitro were identical with those obtained in parallel experiments in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690424      PMCID: PMC53624          DOI: 10.1073/pnas.87.6.2052

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  In vitro synthesis of full-length DNA transcripts of Rous sarcoma virus RNA by viral DNA polymerase.

Authors:  R P Junghans; P H Duesberg; C A Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  The role of RNA molecules in transduction of the proto-oncogene c-fps.

Authors:  C C Huang; N Hay; J M Bishop
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction.

Authors:  S A Herman; J M Coffin
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Retroviral DNA H structures: displacement-assimilation model of recombination.

Authors:  R P Junghans; L R Boone; A M Skalka
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

Review 6.  The molecular genetics of cellular oncogenes.

Authors:  H E Varmus
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

7.  Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination.

Authors:  M P Goldfarb; R A Weinberg
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

8.  Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.

Authors:  S P Goff; C J Tabin; J Y Wang; R Weinberg; D Baltimore
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

Review 9.  Evolution of cancer genes as a mutation-driven process.

Authors:  H M Temin
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

10.  Transduction of a cellular oncogene: the genesis of Rous sarcoma virus.

Authors:  R Swanstrom; R C Parker; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

View more
  42 in total

1.  Homologous recombination of copackaged retrovirus RNAs during reverse transcription.

Authors:  H Stuhlmann; P Berg
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Detection of a novel sense-antisense RNA-hybrid structure by RACE experiments on endogenous troponin I antisense RNA.

Authors:  Holger Bartsch; Stefanie Voigtsberger; Gert Baumann; Ingo Morano; Hans Peter Luther
Journal:  RNA       Date:  2004-08       Impact factor: 4.942

3.  Template switching by reverse transcriptase during DNA synthesis.

Authors:  G X Luo; J Taylor
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.

Authors:  Lu Gao; Mark Nils Hanson; Mini Balakrishnan; Paul L Boyer; Bernard P Roques; Stephen H Hughes; Baek Kim; Robert A Bambara
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

5.  A model system for nonhomologous recombination between retroviral and cellular RNA.

Authors:  A M Hajjar; M L Linial
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

6.  Replication of the retroviral terminal repeat sequence during in vivo reverse transcription.

Authors:  C A Ramsey; A T Panganiban
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

7.  Homologous recombination promoted by reverse transcriptase during copying of two distinct RNA templates.

Authors:  M Negroni; M Ricchetti; P Nouvel; H Buc
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  DNA recombination is sufficient for retroviral transduction.

Authors:  J R Schwartz; S Duesberg; P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Authors:  Miguel E Quiñones-Mateu; Yong Gao; Sarah C Ball; Andre J Marozsan; Awet Abraha; Eric J Arts
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.